Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Polak

Showing results (1-10 of 105) with videos related to

Pageof 11
Sort By:
ALTEX|July 18, 2013
In vitro to human in vivo translation - pharmacokinetics and pharmacodynamics of quinidineSebastian Polak
Journal of Pharmaceutical Sciences|September 20, 2016
Virtual Clinical Trial Toward Polytherapy Safety Assessment: Combination of Physiologically Based Pharmacokinetic/Pharmacodynamic-Based Modeling and Simulation Approach With Drug-Drug Interactions Involving Terfenadine as an ExampleBarbara Wiśniowska, Sebastian Polak
Database : the Journal of Biological Databases and Curation|April 12, 2026
Dataset of xenobiotics human renal clearance valuesNatalia Łapińska, Sebastian Polak
Scientific Reports|January 5, 2017
A four-compartment PBPK heart model accounting for cardiac metabolism - model development and applicationZofia Tylutki, Sebastian Polak
Biopharmaceutics & Drug Disposition|March 14, 2015
Plasma vs heart tissue concentration in humans - literature data analysis of drugs distributionZofia Tylutki, Sebastian Polak
Computers in Biology and Medicine|February 18, 2014
The effects of six antipsychotic agents on QTc--an attempt to mimic clinical trial through simulation including variability in the populationAnna Glinka, Sebastian Polak
Toxicology Mechanisms and Methods|September 26, 2009
hERG in vitro interchange factors--development and verificationBarbara Wiśniowska, Sebastian Polak
Toxicology Mechanisms and Methods|May 9, 2015
QTc modification after risperidone administration--insight into the mechanism of action with use of the modeling and simulation at the population level approachAnna Glinka, Sebastian Polak
Drug Discovery Today|October 9, 2016
Am I or am I not proarrhythmic? Comparison of various classifications of drug TdP propensityBarbara Wiśniowska, Sebastian Polak
Current Pharmacology Reports|December 6, 2016
The Role of Interaction Model in Simulation of Drug Interactions and QT ProlongationBarbara Wiśniowska, Sebastian Polak
Pageof 11

Showing results (1-10 of 105) with videos related to

Sort By:
Pageof 11
ALTEX|July 18, 2013
In vitro to human in vivo translation - pharmacokinetics and pharmacodynamics of quinidineSebastian Polak
Journal of Pharmaceutical Sciences|September 20, 2016
Virtual Clinical Trial Toward Polytherapy Safety Assessment: Combination of Physiologically Based Pharmacokinetic/Pharmacodynamic-Based Modeling and Simulation Approach With Drug-Drug Interactions Involving Terfenadine as an ExampleBarbara Wiśniowska, Sebastian Polak
Database : the Journal of Biological Databases and Curation|April 12, 2026
Dataset of xenobiotics human renal clearance valuesNatalia Łapińska, Sebastian Polak
Scientific Reports|January 5, 2017
A four-compartment PBPK heart model accounting for cardiac metabolism - model development and applicationZofia Tylutki, Sebastian Polak
Biopharmaceutics & Drug Disposition|March 14, 2015
Plasma vs heart tissue concentration in humans - literature data analysis of drugs distributionZofia Tylutki, Sebastian Polak
Computers in Biology and Medicine|February 18, 2014
The effects of six antipsychotic agents on QTc--an attempt to mimic clinical trial through simulation including variability in the populationAnna Glinka, Sebastian Polak
Toxicology Mechanisms and Methods|September 26, 2009
hERG in vitro interchange factors--development and verificationBarbara Wiśniowska, Sebastian Polak
Toxicology Mechanisms and Methods|May 9, 2015
QTc modification after risperidone administration--insight into the mechanism of action with use of the modeling and simulation at the population level approachAnna Glinka, Sebastian Polak
Drug Discovery Today|October 9, 2016
Am I or am I not proarrhythmic? Comparison of various classifications of drug TdP propensityBarbara Wiśniowska, Sebastian Polak
Current Pharmacology Reports|December 6, 2016
The Role of Interaction Model in Simulation of Drug Interactions and QT ProlongationBarbara Wiśniowska, Sebastian Polak
Pageof 11